AkzoNobel Q4 operating income rises to EUR 787 million, up more than sixfold

Reuters
02/03
AkzoNobel Q4 operating income rises to EUR 787 million, up more than sixfold

AkzoNobel reported its fourth quarter (Q4) 2025 earnings, with revenue down 9% to EUR 2.38 billion, driven by lower volumes and negative foreign exchange translation effects. Organic sales declined 1% during the period. Operating income for Q4 2025 increased to EUR 787 million, supported by the completion of the divestment of Akzo Nobel India Ltd, which contributed proceeds of EUR 922 million and an operating income impact of EUR 655 million. Adjusted EBITDA reached EUR 309 million for the quarter, with the adjusted EBITDA margin expanding to 13.0%, up from 12.3% in the previous year, reflecting ongoing efficiency actions. Net cash from operating activities was positive at EUR 462 million in Q4 2025. Key corporate developments include the closing of the sale of Akzo Nobel India Ltd at a valuation of 25 times EBITDA, and a proposed merger with Axalta to create a premier global coatings company. The company also reported a reduction in workforce to 31,500 employees at December 31, 2025, following efficiency programs and the India divestment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akzo Nobel NV published the original content used to generate this news brief on February 03, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10